Targeting CDK12/13 Drives Mitotic Arrest to Overcome Resistance to KRASG12C Inhibitors. Stern YE, Ghosh P, Peroza J, Solanki HS, et al. Cancer Res 2026;86:485-502.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Stern YE, Ghosh P, Peroza J, Solanki HS, et al. Targeting CDK12/13 Drives Mitotic Arrest to Overcome Resistance to KRASG12C Inhibitors. Cancer Res 2026;86:485-502.
PMID: 41165466